Showing 1 - 10 results of 10 for search 'Yosuke Ota', query time: 0.03s Refine Results
  1. 1
    SYNTHESIS, LSD1 INHIBITORY ACTIVITY, AND LSD1 BINDING MODEL OF OPTICALLY PURE LYSINE-PCPA CONJUGATES

    SYNTHESIS, LSD1 INHIBITORY ACTIVITY, AND LSD1 BINDING MODEL OF OPTICALLY PURE LYSINE-PCPA CONJUGATES by Yukihiro Itoh, Daisuke Ogasawara, Yosuke Ota, Tamio Mizukami, Takayoshi Suzuki

    Published 2014-02-01
    Get full text
    Article
  2. 2
    DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment

    DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment by Yosuke Ota, Ryosaku Inagaki, Kentaro Sumida, Megumi Nakamura, Yasuhiro Nagai, Setsuko Yamamoto

    Published 2024-09-01
    Get full text
    Article
  3. 3
    TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation

    TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation by Yosuke Ota, Ryosaku Inagaki, Yasuhiro Nagai, Yuko Hirose, Masashi Murata, Setsuko Yamamoto

    Published 2024-07-01
    Get full text
    Article
  4. 4
    Inversely designed, 3D-printed personalized template-guided interstitial brachytherapy for vaginal tumors

    Inversely designed, 3D-printed personalized template-guided interstitial brachytherapy for vaginal tumors by Shuhei Sekii, Kayoko Tsujino, Kengo Kosaka, Satoshi Yamaguchi, Hikaru Kubota, Yoko Matsumoto, Yosuke Ota, Ryohei Sasaki, Toshinori Soejima

    Published 2018-10-01
    Get full text
    Article
  5. 5
    Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly.

    Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly. by Takayoshi Suzuki, Yuki Kasuya, Yukihiro Itoh, Yosuke Ota, Peng Zhan, Kaori Asamitsu, Hidehiko Nakagawa, Takashi Okamoto, Naoki Miyata

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment

    Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment by Hikaru Kubota, Kayoko Tsujino, Nor Shazrina Sulaiman, Shuhei Sekii, Yoko Matsumoto, Yosuke Ota, Toshinori Soejima, Satoshi Yamaguchi, Ryohei Sasaki

    Published 2019-12-01
    Get full text
    Article
  7. 7
    DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects

    DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects by Yosuke Ota, Yasuhiro Nagai, Yuko Hirose, Seiji Hori, Erina Koga-Yamakawa, Ken Eguchi, Kentaro Sumida, Masashi Murata, Hiroki Umehara, Setsuko Yamamoto

    Published 2023-01-01
    Get full text
    Article
  8. 8
    A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)

    A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinom... by Sadamoto Zenda, Yosuke Ota, Naomi Kiyota, Susumu Okano, Masato Fujii, Morimasa Kitamura, Shunji Takahashi, Tsutomu Ueda, Nobuya Monden, Takeharu Yamanaka, Makoto Tahara

    Published 2019-01-01
    Get full text
    Article
  9. 9
    Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system

    Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system by Hikaru Kubota, Toshinori Soejima, Nor Shazrina Sulaiman, Shuhei Sekii, Yoko Matsumoto, Yosuke Ota, Kayoko Tsujino, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Junichi Ikegaki, Koji Matsumoto, Ryohei Sasaki

    Published 2019-01-01
    Get full text
    Article
  10. 10
    Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

    Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1) by Masahiro Inada, Yasumasa Nishimura, Satoshi Ishikura, Kazuki Ishikawa, Naoya Murakami, Takeshi Kodaira, Yoshinori Ito, Kazuhiko Tsuchiya, Yuji Murakami, Junichi Saito, Tetsuo Akimoto, Kensei Nakata, Michio Yoshimura, Teruki Teshima, Takashi Toshiyasu, Yosuke Ota, Toshiyuki Minemura, Hidetoshi Shimizu, Masahiro Hiraoka

    Published 2022-07-01
    Get full text
    Article

Search Tools: